Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 May;20(5):1049-59.
doi: 10.1007/s10461-015-1192-x.

A Randomized Controlled Trial of Personalized Text Message Reminders to Promote Medication Adherence Among HIV-Positive Adolescents and Young Adults

Robert Garofalo  1   2 , Lisa M Kuhns  3   4 , Anna Hotton  5 , Amy Johnson  3   6 , Abigail Muldoon  3 , Dion Rice  3
Affiliations
Randomized Controlled Trial

A Randomized Controlled Trial of Personalized Text Message Reminders to Promote Medication Adherence Among HIV-Positive Adolescents and Young Adults

Robert Garofalo et al. AIDS Behav. 2016 May.

Abstract

HIV-positive adolescents and young adults often experience suboptimal medication adherence, yet few interventions to improve adherence in this group have shown evidence of efficacy. We conducted a randomized trial of a two-way, personalized daily text messaging intervention to improve adherence to antiretroviral therapy (ART) among N = 105 poorly adherent HIV-positive adolescents and young adults, ages 16-29. Adherence to ART was assessed via self-reported visual analogue scale (VAS; 0-100 %) at 3 and 6-months for mean adherence level and proportion ≥90 % adherent. The average effect estimate over the 6-month intervention period was significant for ≥90 % adherence (OR = 2.12, 95 % CI 1.01-4.45, p < .05) and maintained at 12-months (6 months post-intervention). Satisfaction scores for the intervention were very high. These results suggest both feasibility and initial efficacy of this approach. Given study limitations, additional testing of this intervention as part of a larger clinical trial with objective and/or clinical outcome measures of adherence is warranted.

Trial registration: ClinicalTrials.gov NCT01354210.

Keywords: HIV infection; Medication adherence; Text messaging; Youth.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest/Financial Disclosure: No financial disclosures or conflicts of interest were reported by the authors of this paper.

Figures

Figure 1
Figure 1
CONSORT Diagram – see attached.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention. HIV surveillance report, 2013. Atlanta, GA: 2013.
    1. Centers for Disease Control and Prevention. HIV surveillance report, 2011. Atlanta, GA: 2013.
    1. Osterberg L, Blaschke T. Adherence to medication. New England Journal of Medicine. 2005;353 (5):487–97. - PubMed
    1. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Oct 1;43(7):939–41. Epub 2006/08/31. eng. - PubMed
    1. Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PloS one. 2008;3(7):e2783. Epub 2008/07/31. eng. - PMC - PubMed

Publication types

Associated data